-
Most Recent

Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is BioXcel Therapeutics (BTAI) Stock Down 46% Today?
BioXcel Therapeutics (BTAI) stock is taking a beating on Monday after the biopharmaceutical company announced major layoffs.
Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare
Healthcare stocks are starting to shine in 2023 after bottoming out and MRK stock is particularly appealing. Here's why.
AMRS Stock Surges 152% as Amyris Files for Bankruptcy
Amyris (AMRS) stock is rising higher on Friday with heavy trading after the biotechnology company recently filed for bankruptcy.
Why Is Cano Health (CANO) Stock Down 48% Today?
Cano Health (CANO) stock is taking a beating on Friday after the healthcare company provided a business update in its latest earnings report.
Why is Yield10 Bioscience (YTEN) Stock Down 46% Today?
Yield10 Bioscience (YTEN) stock is falling hard on Friday with heavy trading after a public share offering went into effect.
Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?
Eton Pharmaceuticals (ETON) stock is soaring following the release of its earnings report for the second quarter of 2023!
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
While the story could change down the road, for now your best move is to avoid CMRX stock, even as a small, speculative position.
T2 Biosystems (TTOO) Stock Is Becoming the Next Mullen
Learn from the 99% decline in MULN stock and stay far away from TTOO stock, even if T2 Biosystems is the next big meme on Wall Street.